US Patent Issued to ALS THERAPY DEVELOPMENT INSTITUTE on April 15 for "Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders" (Massachusetts Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,793, issued on April 15, was assigned to ALS THERAPY DEVELOPMENT INSTITUTE (Watertown, Mass.).

"Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders" was invented by John M. Lincecum (Jamaica Plain, Mass.), Bingbing Jiang (Brighton, Mass.), Steven N. Perrin (Newbury, Mass.), Alan Gill (Reading, Mass.), Cynthia A. Gill (Reading, Mass.) and Fernando G. Vieira (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-human CD40L antibodies engineered to lack the ability to activate platelets and methods for treating patients having a CD40L-associated disease."

The patent was filed on June 26, 2023, under Application No. ...